Literature DB >> 11237006

Can sequencing shed light on cell cycling?

A W Murray1, D Marks.   

Abstract

Every organism must have cells that can replicate indefinitely. Can the draft human genome sequence tell us how the cell cycle works and how it evolved? We studied two protein families--the cyclins and their partners the cyclin-dependent kinases (Cdks)--and a conserved regulatory circuit, the spindle checkpoint. Disappointingly, we discovered a few novel cyclins and no new Cdks or components of the spindle checkpoint, and could shed little light on the organization of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237006     DOI: 10.1038/35057033

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  27 in total

1.  Assembly of the working draft of the human genome with GigAssembler.

Authors:  W J Kent; D Haussler
Journal:  Genome Res       Date:  2001-09       Impact factor: 9.043

2.  Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4.

Authors:  Luis M Schang; Andrew Bantly; Priscilla A Schaffer
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Functional cloning, sorting, and expression profiling of nucleic acid-binding proteins.

Authors:  Y Ramanathan; Haibo Zhang; Virginie Aris; Patricia Soteropoulos; Stuart A Aaronson; Peter P Tolias
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

4.  Systematic analysis in Caenorhabditis elegans reveals that the spindle checkpoint is composed of two largely independent branches.

Authors:  Anthony Essex; Alexander Dammermann; Lindsay Lewellyn; Karen Oegema; Arshad Desai
Journal:  Mol Biol Cell       Date:  2008-12-24       Impact factor: 4.138

5.  RON is overexpressed in bladder cancer and contributes to tumorigenic phenotypes in 5637 cells.

Authors:  Jun-Feng Chen; Bi-Xia Yu; Liang Ma; Xiu-Yi Lv; Jun-Hui Jiang; Qi Ma
Journal:  Oncol Lett       Date:  2018-02-28       Impact factor: 2.967

6.  CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome.

Authors:  Vincent J Guen; Carly Gamble; Marc Flajolet; Sheila Unger; Aurélie Thollet; Yoan Ferandin; Andrea Superti-Furga; Pascale A Cohen; Laurent Meijer; Pierre Colas
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

7.  The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.

Authors:  Jitka Holcakova; Peter Tomasec; Joachim J Bugert; Eddie Cy Wang; Gavin Wg Wilkinson; Roman Hrstka; Vladimir Krystof; Miroslav Strnad; Borivoj Vojtesek
Journal:  Antivir Chem Chemother       Date:  2010-01-05

8.  Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation.

Authors:  Hung-Hsi Chen; Yu-Chiuan Wang; Ming-Ji Fann
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma.

Authors:  Cinzia Di Pietro; Marco Ragusa; Davide Barbagallo; Laura R Duro; Maria R Guglielmino; Alessandra Majorana; Rosario Angelica; Marina Scalia; Luisa Statello; Loredana Salito; Luisa Tomasello; Salvo Pernagallo; Salvo Valenti; Vito D'Agostino; Patrizio Triberio; Igor Tandurella; Giuseppe A Palumbo; Piera La Cava; Viviana Cafiso; Taschia Bertuccio; Maria Santagati; Giovanni Li Destri; Salvatore Lanzafame; Francesco Di Raimondo; Stefania Stefani; Bud Mishra; Michele Purrello
Journal:  BMC Med Genomics       Date:  2009-04-30       Impact factor: 3.063

10.  The crystal structure of the N-terminal region of BUB1 provides insight into the mechanism of BUB1 recruitment to kinetochores.

Authors:  Victor M Bolanos-Garcia; Tomomi Kiyomitsu; Sheena D'Arcy; Dimitri Y Chirgadze; J Günter Grossmann; Dijana Matak-Vinkovic; Ashok R Venkitaraman; Mitsuhiro Yanagida; Carol V Robinson; Tom L Blundell
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.